International Day Against Drug Abuse India

As the world observes the International Day Against Drug Abuse and Illicit Trafficking in 2026, this article examines India’s drug control framework under the Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act) at a time of emerging threats. It analyses how strict enforcement, judicial safeguards, and evolving challenges such as synthetic drugs and cyberenabled trafficking call for a more balanced approach that integrates prevention and treatment alongside control.

Observed annually on June 26, the International Day Against Drug Abuse and Illicit Trafficking compels a reflection on real-world impact. Despite an extensive network of international conventions, constitutional directives, and stringent legislations, drug abuse and illicit trafficking continue to persist, inflicting profound social, economic, and institutional harm. Established by UN General Assembly Resolution 42/112 in 1987, this day expresses a global determination to build a drug-free society.

This year’s theme, “World Drug Problem: Persisting Issues, New Challenges, Innovative Responses”, highlights that the contemporary drug problem is no longer confined to traditional supply chains or conventional modes of enforcement.1 Recent incidents, such as the use of Starlink satellite terminals by traffickers to coordinate logistics across open oceans, demonstrate that criminal syndicates are rapidly outpacing traditional border enforcement.

This shifting landscape assumes particular significance in the Indian context. India is located at the intersection of the Golden Crescent and the Golden Triangle, two of the world’s most notorious drug producing regions. India’s primary legal shield, the NDPS Act, remains overwhelmingly punitive. While the law reflects the State’s resolve to curb narcotics, it also raises a critical question for 2026: Has India’s approach evolved beyond controlling the offence to understanding the offender, and beyond suppressing the crime to addressing the conditions that sustain it?

International legal framework

International drug control has developed through a gradual process of legal consolidation, from early efforts such as the Shanghai Opium Commission (1909) and the Opium Convention (1912) to today’s United Nations—led framework, anchored in three core treaties. The 1961 Single Convention on Narcotic Drugs restricts narcotic drugs to medical and scientific use, establishing international scheduling and licensing controls while recognising treatment and rehabilitation as integral to drug control. The 1971 Convention on Psychotropic Substances extends similar controls to synthetic drugs, addressing gaps created by laboratory-manufactured substances, while the 1988 Convention strengthens enforcement against trafficking networks, money laundering, and transnational drug crime.

Together, these treaties form a binding international framework requiring states to criminalise illicit drug activity, regulate the supply of controlled substances, and establish enforcement and reporting systems, though as non-self-executing instruments, their effectiveness ultimately depends on domestic implementation.

From global mandates to sovereign enforcement

The international drug control framework derives its operational force from institutional machinery anchored in the United Nations system. The Commission on Narcotic Drugs (CND), established in 1946, is the principal policy-making body, with authority over the global scheduling of controlled substances. The United Nations Office on Drugs and Crime (UNODC) serves as its secretariat, providing legal guidance, trend analysis, and capacity building for enforcement agencies, while the International Narcotics Control Board (INCB) provides independent oversight, monitoring legal drug production and preventing diversion into illicit markets.

For India, engagement with this apparatus goes beyond formal compliance. As one of the world’s primary producers of legal, pharmaceutical-grade opium and simultaneously a transit corridor for narcotics from the Golden Crescent and Golden Triangle. India occupies a particularly sensitive position, making coordination with the UNODC and INCB essential to protecting its legitimate chemical industries, meeting treaty obligations, and countering transnational trafficking.

This international engagement also shaped India’s domestic legal evolution. Before 1985, Indian drug law was fragmented colonial-era legislation—Opium Act, 1857 and 1878, and the Dangerous Drugs Act, 1930—which were revenue-oriented and ill-suited to synthetic drugs or organised cross-border trafficking. India’s accession to the three UN conventions, coupled with its mandate under Article 47 of the Constitution, necessitated a comprehensive overhaul culminating in the NDPS Act, which consolidated India’s drug laws into a framework aligned with international obligations.

Statutory framework under the NDPS Act

The NDPS Act constitutes India’s principal legal framework for drug control, extending across the whole of India and applying extraterritorially to Indian citizens and Indian-registered vessels and aircraft. The Act regulates two categories of substances, “narcotic drugs”, and “psychotropic substances”, reflecting India’s domestic implementation of the treaty regimes under the 1961 Single Convention and the 1971 Convention on Psychotropic Substances.

Chapter IV of the NDPS Act criminalises a wide spectrum of activities, across the drug supply chain, including possession, manufacture, production, cultivation, transportation, import, export, and trans-shipment. While consumption attracts comparatively lighter penalties, the statutory framework otherwise draws limited distinction between users and traffickers, extending criminal liability to those who finance illicit traffic or harbour offenders.2 Judicial interpretation has emphasised strict compliance with procedural safeguards, particularly where possession is alleged, requiring proof of conscious possession, that is, both physical control and knowledge of the contraband.3

A significant structural feature of the Act is the quantity-based sentencing framework introduced through the 2001 Amendment, which classifies offences into small, commercial and intermediate quantities, with drug-specific thresholds prescribed by the Central Government. These thresholds that determine not just how an offence is classified, but, as the following section sets out, how severely it is punished.

Beyond penal provisions, the NDPS Act establishes a strict licensing and regulatory regime under the Central Bureau of Narcotics to supervise licit opium cultivation, and pharmaceutical manufacture. Enforcement agencies are further empowered through asset forfeiture mechanisms and the recognition of controlled deliveries, enabling surveillance-based operations aimed at dismantling higher-level trafficking networks rather than merely intercepting couriers.4

Punishment under the NDPS Act

The NDPS Act links punishment directly to its quantity-based classification of offences. Violations involving small quantities are punishable with imprisonment of up to one year, a fine, or both. Offences involving intermediate quantities may attract imprisonment of up to 10 years along with a fine. In cases involving commercial quantities, the Act prescribes a mandatory minimum sentence of 10 years’ rigorous imprisonment, extendable to 20 years, in addition to substantial fines.

This regime of mandatory minimum sentencing significantly restricts judicial discretion, as courts are barred from imposing sentences below the prescribed threshold even where mitigating circumstances exist. The Act further enhances penalties for repeat offenders and, in certain cases involving subsequent commercial quantities, permits imposition of the discretionary death penalty.5

By calibrating punishment according to quantity, the statutory framework seeks to balance proportionality with deterrence against organised drug trafficking. How that quantity is calculated, however, remains contested. The Supreme Court has held that the entire weight of a seized mixture, rather than merely the actual narcotic content, determines whether an offence involves a small, intermediate, or commercial quantity.6 The practical consequence is that a small amount of narcotic substance heavily diluted with neutral material may nonetheless attract the severe penalties prescribed for commercial-quantity offences.7 The issue remains unsettled, with the Supreme Court agreeing in September 2025 to reconsider the correctness of this approach.8, 9

The numbers suggest why that distinction matters. NCRB data analysed for 2017—2021 shows that, in every one of those years, more people in India were proceeded against for possession-based offences than for large-scale trafficking10, raising the question of whether the NDPS Act, calibrated as it is around quantity rather than intent, adequately accommodates treatment and rehabilitation-oriented responses for drug abuse, as distinct from drug trafficking.

Procedural and evidentiary safeguards

The NDPS Act confers extensive powers of search, seizure, and arrest, but pairs them with procedural safeguards against arbitrary action. Officers acting on prior information must record their grounds of belief in writing and inform a superior officer within the prescribed time, though searches in public places face lighter requirements11 12 and delayed compliance may be condoned only where satisfactorily explained.13 Among the most significant safeguards is Section 50, entitling a person subjected to personal search to demand it be conducted before a gazetted officer or Magistrate, a requirement the Supreme Court has repeatedly held mandatory, since non-compliance undermines courts’ ability to distinguish genuine recoveries from fabricated evidence; Section 57 separately requires the arresting officer to report the arrest and seizure to a superior within 48 hours.14 15 The courts draw a sharper line here: Sections 42 and 50 are mandatory, while Sections 52 and 57 are merely directory, with non-compliance invalidating proceedings only where it causes actual prejudice to the accused.16 The underlying principle: Procedural safeguards are not technicalities but instruments of fairness within a stringent penal framework.

This evidentiary framework departs further from ordinary criminal jurisprudence. The NDPS Act permits statutory presumptions of mental state and possession to operate against the accused once foundational facts, including conscious possession, are established by the prosecution.17 The Supreme Court has upheld this as constitutional, clarifying that the presumptions are rebuttable, do not produce automatic conviction, and require the accused to establish only a probable defence on a balance of probabilities.18 For this reason, strict compliance with seizure, sampling, and storage procedures carries heightened weight in NDPS prosecutions: Any serious lapse can prevent the presumption from being invoked at all. Read together, these provisions and the safeguards above reveal the Act’s broader design, extensive enforcement power matched with strict procedural discipline, leaving courts to ensure that combating drug offences does not come at the cost of fairness, due process, and constitutional liberty.

Bail under the NDPS Act: Rigour, restrictions, and liberty

The NDPS Act incorporates one of the most restrictive bail regimes in Indian criminal law. In cases involving commercial quantities of narcotic drugs and psychotropic substances, financing of illicit traffic, and certain other serious offences, bail may be granted only after the prosecution is heard and the court is satisfied that there are reasonable grounds to believe that the accused is not guilty and is unlikely to commit any offence while on bail.19

Judicial interpretation has consistently emphasised the exceptional nature of this regime. The Supreme Court has clarified that the requirement of “reasonable grounds” demands more than a prima facie assessment and must rest on substantial and probable material indicating innocence.20 Consequently, a liberal approach to bail is ordinarily considered inappropriate in prosecutions under the Act.

This stringent framework reflects legislative concern over organised drug trafficking, but it has also raised constitutional questions. Prolonged pre-trial detention, particularly in cases marked by delayed trials, has been recognised as implicating the right to personal liberty. Courts have therefore acknowledged that excessive delay in the conclusion of the trial may, in appropriate circumstances, justify the grant of bail notwithstanding the rigours of the statutory regime.

Modern frontiers: Cyber-trafficking, synthetics, and the challenges of 2026

Enforcement under the NDPS Act operates through a multiagency framework spanning Central and State authorities. The Narcotics Control Bureau (NCB) is the nodal coordinating body, though judicial interpretation has clarified its role is coordinative rather than autonomous, with enforcement powers flowing from authorisation under the Act.21 The Narcotics Commissioner oversees licit opium cultivation and the regulated pharmaceutical supply chain, while State police, Customs, and the Directorate of Revenue Intelligence exercise search, seizure, and arrest powers under the Act. It is this enforcement architecture, built for physical searches, seizures, and territorial jurisdiction, that now faces its sharpest test.

The landscape of drug trafficking has shifted rapidly, exposing the limits of laws built for a physical world. This year’s UNODC theme for the Day captures that shift: “The World Drug Problem: Persisting Issues, New Challenges, Innovative Responses.”22 Plant-based narcotics are increasingly being replaced by synthetic drugs, such as fentanyl and methamphetamine. These substances are cheap to produce, easy to transport, and largely disconnected from traditional geographic supply chains.23

At the same time, trafficking has moved into the digital domain. Encrypted messaging platforms, dark web marketplaces, cryptocurrencies, and satellite-based coordination now enable decentralised operations that bypass territorial borders altogether.24 For legal frameworks centred on physical searches, seizures, and land-based enforcement, this shift creates a serious enforcement gap. The scale, for now, is still small on paper: Per a government reply in the Rajya Sabha, the Narcotics Control Bureau booked just 92 cases involving the dark web and cryptocurrency between 2020 and April 2024, against roughly 38,000 NDPS trafficking cases registered nationwide in 2022 alone,25 a gap that may reflect under-detection as much as actual prevalence.

Closing that gap will mean investing in digital intelligence and cross-border coordination, not simply adding more boots on the ground.

Innovative responses: From statutory provision to institutional practice

The NDPS Act’s punitive architecture has always carried a less-noticed treatment-oriented counterpart. Section 64-A extends immunity from prosecution to addicts who voluntarily undergo treatment for de-addiction, Section 39 allows courts to release certain offenders for treatment instead of prosecution, and Section 71 empowers the Government to establish, recognise or approve centres for the identification, treatment, after-care, rehabilitation and social re-integration of addicts.26

In practice, this statutory machinery has historically suffered from uneven implementation. For decades, only a handful of States framed comprehensive rules to licence and regulate de-addiction facilities under Section 71, leaving vast numbers of treatment centres operating without binding minimum standards. However, this administrative inertia has been increasingly challenged by the judiciary. Following expansive monitoring directives from the Supreme Court in cases concerning institutional exploitation, the executive machinery has been pushed to mandate standardised licensing protocols across all States.27

Government programming has tried to close that gap from the demand-reduction side. The National Action Plan for Drug Demand Reduction, run by the Ministry of Social Justice and Empowerment, channels funding to roughly 480 Integrated Rehabilitation Centres for Addicts across the country,28 while the Nasha Mukt Bharat Abhiyaan, the Ministry’s flagship outreach campaign has expanded from 272 originally identified vulnerable districts to nationwide coverage.29 In a detail that underscores this year’s UNODC framing, the campaign’s 2026 outreach week, the Nasha Mukt Bharat Saptah, was timed to run from 17 June to 26 June, concluding on this very day.30

These remain demand-side measures layered onto a supply-side statute, rather than a fully integrated framework. But they are precisely the kind of innovative response this year’s theme calls for: Not a retreat from enforcement, but its pairing with treatment infrastructure built to scale. Whether India treats Section 71 as a dormant power or an active obligation may do more to shape the next decade of drug policy than any further amendment to Chapter IV’s penal provisions.

Conclusion

India’s drug control framework reflects a deliberate emphasis on deterrence and enforcement, shaped by international obligations and embodied in the NDPS Act’s stringent penal structure. This approach seeks to combat organised and transnational drug trafficking, yet its rigidity has also exposed limitations when applied to drug abuse as a social and public health concern.

Judicial interpretation has played a critical role in tempering this severity by reinforcing procedural safeguards, protecting personal liberty, and preventing misuse of enforcement powers. Yet, judicial intervention can only operate within the confines of a statute fundamentally oriented towards punishment.

As drug abuse continues to persist despite strict laws, the challenge lies not in weakening enforcement, but in recalibrating the response, ensuring that control mechanisms are complemented by prevention, treatment, and rehabilitation. This is, in the end, what this year’s UNODC theme asks of every state party: To treat innovative, treatment-oriented responses not as an adjunct to enforcement but as a co-equal pillar of it. On this International Day Against Drug Abuse and Illicit Trafficking, the need is not merely for stronger laws, but for a more balanced and humane framework capable of addressing both the crime and the condition.


*Senior Editorial Assistant (Legal), EBC Publishing Pvt. Ltd with research assistance from Dewansh Mohan Srivastava, 2nd Year Student, NLU Jodhpur. Author can be reached at: arushi.pandey@ebcpublishing.in.

1. United Nations International Day Against Drug Abuse and Illicit Trafficking, available at <https://www.un.org/en/observances/end-drug-abuse-day>.

2. Narcotic Drugs and Psychotropic Substances Act, 1985, Ss. 27-A and 29.

3. Sorabkhan Gandhkhan Pathan v. State of Gujarat, (2004) 13 SCC 608.

4. Narcotic Drugs and Psychotropic Substances Act, 1985 S. 50-A; Narcotic Drugs and Psychotropic Substances Act, 1985 Chapter V-A, Ss. 68-A to 68-Y.

5. Narcotic Drugs and Psychotropic Substances Act, 1985, Ss. 31 and 31-A.

6. Hira Singh v. Union of India, (2020) 20 SCC 272.

7. Hira Singh v. Union of India, (2020) 20 SCC 272.

8. Hira Singh v. Union of India, (2020) 20 SCC 272.

9. E. Micheal Raj v. Narcotic Control Bureau, (2008) 5 SCC 161

10. Yatan Pal Singh Balhara, Siddharth Sarkar and Akanksha Jayant Rajguru, “Drug-related Offences in India: Observations and Insights from the Secondary Analysis of the Data from the National Crimes Record Bureau” (2024) 46(6) Indian Journal of Psychological Medicine.

11. Karnail Singh v. State of Haryana, (2009) 8 SCC 539.

12. Narcotic Drugs and Psychotropic Substances Act, 1985, S. 43.

13. State of Punjab v. Balbir Singh, (1994) 3 SCC 299.

14. State of Punjab v. Baldev Singh, (1999) 6 SCC 172.

15. Narcotic Drugs and Psychotropic Substances Act, 1985, S. 57.

16. State of Punjab v. Balbir Singh, (1994) 3 SCC 299.

17. Narcotic Drugs and Psychotropic Substances Act, 1985, Ss. 35 and 54

18. Noor Aga v. State of Punjab, (2008) 16 SCC 417.

19. Narcotic Drugs and Psychotropic Substances Act, 1985, S. 37.

20. State of Kerala v. Rajesh, (2020) 12 SCC 122.

21. Tofan Singh v. State of T.N., (2021) 4 SCC 1.

22. “CND Chair’s Special Event to commemorate the International Day against Drug Abuse and Illicit Trafficking and to launch the 2026 UNODC World Drug Report” UNODC.

23. UNODC, World Drug Report, 2025.

24. Ministry of Home Affairs, Narcotics Control Bureau, Government of India, Annual Report 2023.

25. Press Release, Drug Trafficking in the Country, 24-7-2024.

26. Narcotic Drugs and Psychotropic Substances Act, 1985, Ss. 39, 64-A and 71.

27. Exploitation of Children in Orphanages, In re, (2017) 7 SCC 578.

28. Government of India, Ministry of Social Justice and Empowerment, Scheme of National Action Plan for Drug Demand Reduction, available at <https://grants-msje.gov.in/display-napddr-action-plan>.

29. Ministry of Social Justice and Empowerment, Nasha Mukt Bharat Abhiyaan, available at <https://socialjustice.gov.in/common/52569>.

30. Ministry of Social Justice & Empowerment, Nasha Mukt Bharat Abhiyaan, Nasha Mukt Bharat Saptah 2026, observed from 17-6-2026 to 26-6-2026, available at <https://nmba.dosje.gov.in/>.

Join the discussion

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.